Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions